Amyloid duration is associated with preclinical cognitive decline and tau PET-Reference-Cited by-同舟云学术

Amyloid duration is associated with preclinical cognitive decline and tau PET

Published:2020-01 Issue:1 Volume:12 Page:
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Koscik Rebecca L.¹²,Betthauser Tobey J.²³,Jonaitis Erin M.¹²,Allison Samantha L.²³⁴,Clark Lindsay R.²³⁴,Hermann Bruce P.¹⁵,Cody Karly A.²³,Engle Jonathan W.⁶,Barnhart Todd E.⁶,Stone Charles K.²,Chin Nathaniel A.²³,Carlsson Cynthia M.¹²³⁴,Asthana Sanjay²³⁴,Christian Bradley T.³⁶⁷,Johnson Sterling C.¹²³⁴

Affiliation:

1. Wisconsin Alzheimer's Institute University of Wisconsin School of Medicine and Public Health Madison Wisconsin

2. Department of Medicine University of Wisconsin School of Medicine and Public Health Madison Wisconsin

3. Wisconsin Alzheimer's Disease Research Center University of Wisconsin School of Medicine and Public Health Madison Wisconsin

4. Geriatric Research Education and Clinical Center William S. Middleton Memorial Veterans Hospital Madison Wisconsin

5. Department of Neurology University of Wisconsin School of Medicine and Public Health Madison Wisconsin

6. Department of Medical Physics University of Wisconsin‐Madison Madison Wisconsin

7. Waisman Laboratory for Brain Imaging and Behavior University of Wisconsin‐Madison Madison Wisconsin

Funder

National Institutes of Health

Alzheimer's Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dad2.12007

Reference41 articles.

1. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

2. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

3. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

4. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

5. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloid age and tau PET timeline to symptomatic Alzheimer’s disease in Down syndrome;2024-08-09

2. Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration;Alzheimer's Research & Therapy;2024-07-03

3. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease;Brain;2024-04-26

4. Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD‐risk‐enriched cohorts;Alzheimer's & Dementia;2024-03-27

5. CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges;CLIN CHEM;2024